GlobeNewswire Releases AI in Drug Discovery Report Detailing Market Analysis and Future Forecasts

AI in Drug Discovery Report – GlobeNewswire issued a 2026 research report titled “AI in Drug Discovery Research Report 2026,” delivering a comprehensive global market analysis of artificial‑intelligence applications in pharmaceutical discovery, covering industry size, growth drivers, and key challenges.

Competitive Landscape – The report maps the competitive landscape, listing major AI‑driven drug discovery companies, their market positions, and strategic initiatives, highlighting how firms are leveraging machine learning to accelerate target identification and compound optimization.

Opportunities Identified – It identifies emerging opportunities, such as integration of AI with clinical trial design, partnerships between biotech firms and tech providers, and investment trends that could reshape the drug development pipeline over the next decade.

Forecast Periods – Forecasts span two intervals, 2021‑2025 and 2025‑2031, projecting market trends, adoption rates, and potential revenue growth for AI‑enabled discovery platforms, offering stakeholders long‑term insight into the sector’s evolution.